Product Images Pirfenidone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Pirfenidone NDC 16729-468 by Accord Healthcare Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
267 mg 90 Tablets - pirfenidone 267mg 90tablets
Each film-coated tablet has 267 mg of pirenidone. It is vital to check the package insert for dosage and administration information. The product should be stored between 15°C and 30°C (59°F to 86°F), excursions are permitted to 25°C (T7°F), as indicated by USP Controlled Room Temperature. The medication is produced by Intas Pharmaceuticals Limited in Ahmedabad, INDIA, and distributed by Accord Healthcare, Inc, in Durham, NC 27703. The product's name is Pirfenidone Tablets, and the package contains 90 tablets. For additional details, there is a symbol indicating that the area must be clear and free of any information for overcading Lot and EXP & Data Matrix.*
801 mg 90 Tablets - pirfenidone 801mg 90tablets
This text describes a medication called Pirfenidone in the form of film coated tablets, with each containing 801mg of the medication. The recommended dosage details are provided in the package insert. The tablets should be stored within a specific temperature range and kept out of reach of children. The medication is manufactured for Accord Healthcare in North Carolina and is produced by Intas Pharmaceuticals in India. The tablet's lot and expiration details are provided along with a unique identification number.*
Figure 1 - pirfenidone figure1
This text appears to be a chart presenting data for patients taking Pirfenidone and Placebo, measuring Worsening (decrease in %FVC) and No Decline (increase in %FVC) over 52 weeks. The numbers in the chart correspond to the percentage of patients experiencing either worsening or no decline. The text also includes the absolute change in %FVC from baseline to week 52.*
Figure 2 - pirfenidone figure2
This is a chart showing the Mean Change in Forced Vital Capacity (FVC) in milliliters (mL) for two groups of participants: the Pirfenidone group with 278 participants and the Placebo group with 277 participants. The chart displays the range of values from -400 mL to 500 mL over a period of 52 weeks.*
Figure 3 - pirfenidone figure3
This is a clinical trial report comparing the effectiveness of Pirfenidone against Placebo in treating a certain condition. The graph shows the percentage of patients who are still alive during the course of several weeks. The table presents the number of patients who are still in the study at different times.*
Chemical Structure - pirfenidone structural formula
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.